European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis: Haematologica 2012;97(3):360-5 - Comment

Haematologica

Volumn 97, Issue 3, 2012, Pages

  Thiele, Jürgen ^a   Orazi, Attilio ^b   Kvasnicka, Hans Michael ^c   Franco, Vito ^d   Boveri, Emanuela ^e   Gianelli, Umberto ^f   Gisslinger, Heinz ^g   Passamonti, Francesco ^h   Tefferi, Ayalew ⁱ   Barbui, Tiziano ^j  

^a UNIVERSITY OF COLOGNE   (Germany)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF PALERMO   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

^h OSPEDALE DI CIRCOLO   (Italy)

ⁱ MAYO CLINIC   (United States)

^j OSPEDALI RIUNITI   (Italy)

more..

Author keywords

Early primary myelofibrosis; Essential thrombocythemia; WHO classification

Indexed keywords

LACTATE DEHYDROGENASE;

ANEMIA; CLINICAL EVALUATION; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; MYELOFIBROSIS; MYELOPHTHISIC ANEMIA; POLYCYTHEMIA; PRACTICE GUIDELINE; PREVALENCE; REPRODUCIBILITY; SPLENOMEGALY; THROMBOCYTHEMIA; WORLD HEALTH ORGANIZATION;

EID: 84857775547     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.061432     Document Type: Letter

References (12)

1. Buhr T, Hebeda K, Kaloutsi V, Porwit A, Van der Walt J, Kreipe H. European Bone Marrow Working Group trial on reproducibility of WHO criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica. 2012;97(3):360-5.
2. Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007;110(4): 1092-7.
3. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937-51.
4. Thiele J, Kvasnicka HM, Tefferi A, Barosi G, Orazi A, Vardiman JW, et al. Primary myelofibrosis. In: Swerdlow S, Campo E, Harris N et al (2008) WHO Classification of Tumours of Haematopoietic and Lympoid Tissues. IARC Press, Lyon, France, p 44-7.
5. Thiele J, Kvasnicka HM, Diehl V. Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia. Acta Haematol. 2005;113(4):213-9.
6. Gianelli U, Iurlo A, Vener C, Moro A, Fermo E, Bianchi P, et al. The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia. Am J Clin Pathol. 2008;130(3):336-42.
7. Thiele J, Kvasnicka HM, Müllauer L, Buxhofer-Ausch V, Gisslinger B, Gisslinger H. Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification. Blood. 2011;117(21):5710-8.
8. Barbui T, Thiele J, Passamonti F, Rumi E, Boveri E, Ruggeri M, et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study of 1,104 patients. J Clin Oncol. 2011;29(23): 3179-84.
9. Wilkins BS, Erber WN, Bareford D, Buck G, Wheatley K, East CL, et al. Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes. Blood. 2008;111(1):60-70.
10. Kvasnicka HM, Thiele J. Prodromal myeloproliferative neoplasms: The 2008 WHO classification. Am J Hematol. 2010;85(1):62-9.
11. Brousseau M, Parot-Schinkel E, Moles MP, Boyer F, Hunault M, Rousselet MC. Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis. Histopathology. 2010;56(6):758-67.
12. Buhr T, Buesche G, Choritz H, Länger F, Kreipe H. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens. Am J Clin Pathol. 2003 119(1):152-8.